CD8A and breast carcinoma: Nanoparticle-conjugated gasdermin can induce the pyroptosis of 15% of breast cancer cells, which can enhance the antitumor immunity effect of CD8 + T cells and finally clear the entire 4T1 mammary tumor graft [40].